Recent Finacing
Recent Raise
Bioarray Genetics develops gene-signature and algorithm-based diagnostics, including BA100, an RNA-biomarker breast cancer test predicting chemotherapy response from initial tumor biopsies for stage 1–3 and triple-negative patients.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors